Therefore, it is not the intent of this review to repeat what has previously been written, but to summarize what is known about GLP-1 with a focus on gene therapy using expression vectors of GLP-1 and other incretin mimetics in the salivary gland for the treatment of type 2 diabetes mellitus (T2DM). Here, GLP1R is linked to type 2 diabetes mellitus.